TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27721170

Group type: EXPERIMENTAL
Intervention: Laparoscopic pelvic trainer training (Group A)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Laparoscopic pelvic trainer training (Group B)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No training (Group A between T2 and T3)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No training (Group B before T3)
Number of subjects: 26
Study: 24508516

Group type: EXPERIMENTAL
Intervention: Continuous enteral nutrition (CEN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bolus enteral nutrition (BEN)
Number of subjects: 30
Study: 22929730

Group type: EXPERIMENTAL
Intervention: Low-dose dexmedetomidine (target = 0.15 ng/ml plasma)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 20691128

Group type: EXPERIMENTAL
Intervention: Green tea
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Coffee
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Coffee and Green tea
Number of subjects: 9
Study: 18362507

Group type: EXPERIMENTAL
Intervention: Growth hormone therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Untreated non-GHD short children (control)
Number of subjects: 20
Study: 17190940

Group type: EXPERIMENTAL
Intervention: MCI-single domain
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: MCI-multiple domains
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: Nonamnestic MCI
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: Amnestic MCI
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: MCI modified, 1.0 SD criteria
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: Nonamnestic MCI-multiple domains
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: Alzheimer disease (AD)
Number of subjects: 980
Study: 14520131

Group type: EXPERIMENTAL
Intervention: Gabapentin (400 mg qid)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 11105733

Group type: EXPERIMENTAL
Intervention: Herbal and over-the-counter antidepressants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamins and amino acids for depression
Number of subjects: 0
Study: 8957975

Group type: EXPERIMENTAL
Intervention: Increasing CPB flow rates from 2.4 to 3.0 litre min‐1 m‐2
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dopamine 6 micrograms kg‐1 min‐1
Number of subjects: 12
Study: 1558003

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment for ISH
Number of subjects: 0
Study: 3891285

Group type: EXPERIMENTAL
Intervention: Filtered amphotericin B infusions (1 micron filter)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Unfiltered amphotericin B infusions
Number of subjects: 15
Study: 31949235

Group type: EXPERIMENTAL
Intervention: Google Earth elevation data extraction and correction regression model (CRM)
Number of subjects: 15086

Group type: COMPARATOR
Intervention: Google Earth elevation data extraction
Number of subjects: 15086
Study: 29164960

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 0.05% cream plus emollient (Group A)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Emollient alone (Group B)
Number of subjects: 123
Study: 27470152

Group type: EXPERIMENTAL
Intervention: Cefazolin 2 g intravenously 30 minutes prior to the procedure (n = 91)
Number of subjects: 180
Study: 26133206

Group type: EXPERIMENTAL
Intervention: Lavender and sleep hygiene
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sleep hygiene alone
Number of subjects: 79
Study: 23966329

Group type: EXPERIMENTAL
Intervention: Healthy eating and physical activity intervention
Number of subjects: 542

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 542
Study: 20371663

Group type: EXPERIMENTAL
Intervention: HbA1c level of 6.1%
Number of subjects: 1972

Group type: EXPERIMENTAL
Intervention: HbA1c level of 6.5% (+/‐2 SD)
Number of subjects: 1972

Group type: EXPERIMENTAL
Intervention: HbA1c level of 7% (+/‐2.7 SD)
Number of subjects: 1972

Group type: EXPERIMENTAL
Intervention: HbA1c level of 6.5%
Number of subjects: 1972

Group type: EXPERIMENTAL
Intervention: HbA1c level of 7%
Number of subjects: 1972
Study: 18680228

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg daily for 3 years)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo (matched identical placebo for 3 years)
Number of subjects: 137
Study: 15897687

Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac-Na Emulgel applied 6 and 10 hours after irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single application of 0.1% diclofenac-Na Emulgel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second application of 0.1% diclofenac-Na Emulgel 4 hours after the first
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 14559424

Group type: EXPERIMENTAL
Intervention: Handling time interval for lifting tasks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Handling time interval for lowering tasks
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Load weights (10, 15, and 20 kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ranges of motion (FS, KS, SF, FK, KF, SK)
Number of subjects: 9
Study: 10383544

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 11
Study: 8905278

Group type: COMPARATOR
Intervention: High dose fentanyl/midazolam anesthesia
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Thoracolumbar epidural blockade with high dose fentanyl/midazolam anesthesia
Number of subjects: 27
Study: 1893006

Group type: EXPERIMENTAL
Intervention: Thymostimulin (TP-1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not receiving thymostimulin)
Number of subjects: 40
Study: 6410898

Group type: EXPERIMENTAL
Intervention: 1 g/kg ideal body weight amino acid infusion
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 2 g/kg ideal body weight amino acid infusion
Number of subjects: 5
Study: 31888241

Group type: EXPERIMENTAL
Intervention: Plant extracts (Berberis aristata, Elaeis guineensis, Coffea canephora)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 29871849

Group type: EXPERIMENTAL
Intervention: SBRT + CGA
Number of subjects: 51

Group type: COMPARATOR
Intervention: SBRT - CGA
Number of subjects: 51
Study: 27271320

Group type: EXPERIMENTAL
Intervention: Temperature at 20°C
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Temperature at 25°C
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Temperature at 5°C
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Temperature at 10°C
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Temperature at 15°C
Number of subjects: 4
Study: 24107112

Group type: EXPERIMENTAL
Intervention: 400 mg naltrexone (high-dosage group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 200 mg naltrexone (low-dosage group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Injectable depot naltrexone (400 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (in both panels)
Number of subjects: 36
Study: 22991696

Group type: EXPERIMENTAL
Intervention: Bepotastine besilate ophthalmic solution 1.5% (BBOS)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 20622475

Group type: EXPERIMENTAL
Intervention: Statin treatment (at least 5 days before operation)
Number of subjects: 584

Group type: COMPARATOR
Intervention: No statin treatment
Number of subjects: 584
Study: 17182810

Group type: EXPERIMENTAL
Intervention: Zinc plus IFA
Number of subjects: 94359

Group type: COMPARATOR
Intervention: IFA alone
Number of subjects: 94359
Study: 15138760

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.3 mg/kg acute dose
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.6 mg/kg acute dose
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Chronic Methylphenidate administration
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (healthy boys)
Number of subjects: 75
Study: 12243813

Group type: EXPERIMENTAL
Intervention: Oxaliplatin (OXA) 25 mg/m²/day in 30-min infusions, bolus leucovorin (LV) 20 mg/m²/day, bolus 5-FU 375 mg/m²/day, given on 4 days during Weeks 1 and 5 of radiotherapy (50.4 Gy). A single OXA dose (50 mg/m²) was given on the third week of radiotherapy.
Number of subjects: 22
Study: 11165426

Group type: EXPERIMENTAL
Intervention: Active treatment with exposure therapy in a group context
Number of subjects: 6

Group type: COMPARATOR
Intervention: Comparison treatment avoiding trauma focus
Number of subjects: 6
Study: 9279199

Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 60 degrees head-up tilt
Number of subjects: 23
Study: 8235009

Group type: EXPERIMENTAL
Intervention: 12‐14 weeks unsupervised physical training at home
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (informally encouraged to practice exercise)
Number of subjects: 118
Study: 3551570

Group type: EXPERIMENTAL
Intervention: Doppler method B for measurement of atrial depressurization time
Number of subjects: 200

Group type: COMPARATOR
Intervention: Doppler method A for measurement of atrial depressurization time
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Doppler method B
Number of subjects: 200
Study: 29339313

Group type: EXPERIMENTAL
Intervention: androstadienone (AND)
Number of subjects: 80
Study: 27214168

Group type: EXPERIMENTAL
Intervention: Blended‐ABCT (5 individual CBT sessions and 7 sessions of ABCT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: ABCT (Alcohol Behavioral Couple Therapy)
Number of subjects: 59
Study: 24309905

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 20-70 mg/day
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX)
Number of subjects: 143
Study: 23620396

Group type: EXPERIMENTAL
Intervention: High-flux dialysis
Number of subjects: 704

Group type: COMPARATOR
Intervention: Low-flux dialysis
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: High-flux dialysis (subgroup with arteriovenous fistulas)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: High-flux dialysis (diabetic subjects)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Ultrapure dialysate (subjects with more than 3 years of dialysis)
Number of subjects: 704

Group type: COMPARATOR
Intervention: Ultrapure dialysate
Number of subjects: 704

Group type: COMPARATOR
Intervention: Standard dialysate
Number of subjects: 704
Study: 20384496

Group type: EXPERIMENTAL
Intervention: 2 doses of 7-valent PCV (PCV7) at ages 4 and 6 months
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: 3 doses of 7-valent PCV (PCV7) at ages 2, 4, and 6 months
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Booster dose of PCV7 at age 12 months
Number of subjects: 545

Group type: COMPARATOR
Intervention: Noncarried serotypes
Number of subjects: 545
Study: 18764815

Group type: EXPERIMENTAL
Intervention: MM group
Number of subjects: 296

Group type: COMPARATOR
Intervention: Fe group
Number of subjects: 296

Group type: COMPARATOR
Intervention: IZ group
Number of subjects: 296
Study: 16395845

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 44

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 44
Study: 12971419

Group type: EXPERIMENTAL
Intervention: Protocol A (three equal, divided doses given with meals over 10 h)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Protocol B (three equal doses over 14 h)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Protocol C (four equal doses over 14 h)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Protocol D (six equal doses over 24 h)
Number of subjects: 16
Study: 10480516

Group type: EXPERIMENTAL
Intervention: Insulin aspart (0.2 U/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular insulin (0.2 U/kg)
Number of subjects: 20
Study: 8917741

Group type: EXPERIMENTAL
Intervention: High-saturated fat (SFA) diet
Number of subjects: 55

Group type: COMPARATOR
Intervention: Low-saturated/high-polyunsaturated-fat (PUFA) diet
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: ApoB SP24 allele presence
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: LPL HindIII genotype H+ H+
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: ApoCIII genotype CC
Number of subjects: 55
Study: 1865551

Group type: EXPERIMENTAL
Intervention: Taurine-supplemented soft diet (40 mumol/kg per day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ordinary postoperative soft diet
Number of subjects: 18
Study: 31805675

Group type: EXPERIMENTAL
Intervention: Herbs and Spices (H&S) added to low-salt legume-based dishes (0.4% w/w)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Low-salt legume-based dishes (0.4% w/w) without H&S (LS)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard salt legume-based dishes (0.8% w/w) (S)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Low-salt legume-based dishes with H&S (LSHS)
Number of subjects: 94
Study: 27570169

Group type: EXPERIMENTAL
Intervention: Patella tendon autograft (BPTB)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Hamstring autograft (HS)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tibialis anterior allograft (TA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 26382279

Group type: EXPERIMENTAL
Intervention: peginterferon alpha-2a
Number of subjects: 76

Group type: COMPARATOR
Intervention: interferon alpha-2a
Number of subjects: 76
Study: 24510496

Group type: EXPERIMENTAL
Intervention: 15 g twice daily of creatine monohydrate
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 22237819

Group type: EXPERIMENTAL
Intervention: modified Story Memory Technique (mSMT) treatment (n = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo-control (n = 8)
Number of subjects: 16
Study: 20064185

Group type: EXPERIMENTAL
Intervention: MAL PDT (methyl aminolevulinate) applied as cream 160 mg/g for 3 hours, followed by illumination with broad-spectrum red light (75 J/cm², 570-670 nm), repeated 7 days later.
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo cream applied for 3 hours, followed by illumination with broad-spectrum red light (75 J/cm², 570-670 nm), repeated 7 days later.
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: MAL PDT (methyl aminolevulinate)
Number of subjects: 131
Study: 17457126

Group type: EXPERIMENTAL
Intervention: 2.5 microg/kg scopolamine
Number of subjects: 100

Group type: COMPARATOR
Intervention: 10 microg/kg atropine
Number of subjects: 100
Study: 15050067

Group type: EXPERIMENTAL
Intervention: Hertel exophthalmometry
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Optical 3D imaging
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Computed tomography
Number of subjects: 32
Study: 12182270

Group type: EXPERIMENTAL
Intervention: Cognitive-Processing Therapy (CPT)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure
Number of subjects: 171

Group type: COMPARATOR
Intervention: Minimal Attention (MA)
Number of subjects: 171
Study: 9696367

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HD-MTX) consolidation and reintensification
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Combination of multidrug induction, HD-MTX consolidation, and reintensification
Number of subjects: 3500

Group type: COMPARATOR
Intervention: Conventional doses of methotrexate
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Short intensive chemotherapy pulses including HD-MTX
Number of subjects: 3500

Group type: EXPERIMENTAL
Intervention: Post-consolidation cranial radiotherapy (CRT)
Number of subjects: 3500
Study: 7848669

Group type: EXPERIMENTAL
Intervention: Trained residents delivering stage-based smoking cessation advice
Number of subjects: 252

Group type: COMPARATOR
Intervention: Untrained residents (usual care)
Number of subjects: 252
Study: 2503640

Group type: EXPERIMENTAL
Intervention: Liquid polymer diet (Fresubin)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Continuous intraduodenal application of liquid hydrolysed diet (Survimed OPD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standardized normal meal
Number of subjects: 10
Study: 403921

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 33

Group type: COMPARATOR
Intervention: Gold
Number of subjects: 33

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 33
Study: 31159655

Group type: EXPERIMENTAL
Intervention: Plyometric jump training with 30s inter-set recovery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plyometric jump training with 120s inter-set recovery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control period (no plyometric training)
Number of subjects: 0
Study: 28637287

Group type: EXPERIMENTAL
Intervention: LA-EP2006
Number of subjects: 624

Group type: COMPARATOR
Intervention: Reference pegfilgrastim
Number of subjects: 624
Study: 25851616

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate
Number of subjects: 391

Group type: COMPARATOR
Intervention: Oral antipsychotics
Number of subjects: 391
Study: 23265705

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CRT) and lapatinib followed by lapatinib
Number of subjects: 67

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CRT) and placebo followed by placebo
Number of subjects: 67
Study: 20950940

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Depressed subjects
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Unmedicated patients
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Medicated patients
Number of subjects: 176
Study: 19433150

Group type: EXPERIMENTAL
Intervention: Coaching Our Acting‐Out Children: Heightening Essential Skills (COACHES) program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Behavioral Parent Training (BPT) program
Number of subjects: 0
Study: 17084249

Group type: EXPERIMENTAL
Intervention: Torcetrapib 10, 30, 60, or 90 mg/day
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Torcetrapib 90 mg/day
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Torcetrapib 60 mg/day
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Torcetrapib
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study: 15588745

Group type: EXPERIMENTAL
Intervention: E-Diaries
Number of subjects: 177

Group type: COMPARATOR
Intervention: T-Diaries
Number of subjects: 177

Group type: COMPARATOR
Intervention: P-Diaries
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: All methods
Number of subjects: 177
Study: 11748389

Group type: EXPERIMENTAL
Intervention: Adaptive support ventilation (ASV)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (control)
Number of subjects: 49
Study: 9280206

Group type: EXPERIMENTAL
Intervention: Dietary salt restriction with a low-salt diet (20 mmol sodium chloride per day) and a supplement of 20 tablets of slow sodium (10 mmol NaCl per tablet) for 7 days
Number of subjects: 90
Study: 8301803

Group type: EXPERIMENTAL
Intervention: TPN during chemotherapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: CT only
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: TPN
Number of subjects: 43

Group type: COMPARATOR
Intervention: CT
Number of subjects: 43
Study: 3546185

Group type: EXPERIMENTAL
Intervention: Hexabrix
Number of subjects: 52

Group type: COMPARATOR
Intervention: Hypaque M60
Number of subjects: 52
Study: 30956054

Group type: EXPERIMENTAL
Intervention: Capsaicin intervention group
Number of subjects: 69
Study: 28062538

Group type: EXPERIMENTAL
Intervention: Baseline estimated pulmonary artery diastolic pressure (ePAD)
Number of subjects: 790

Group type: EXPERIMENTAL
Intervention: Change in ePAD from baseline to 6 months
Number of subjects: 790

Group type: EXPERIMENTAL
Intervention: Change in ePAD from baseline to 14 days before death or exit from study
Number of subjects: 790

Group type: EXPERIMENTAL
Intervention: Area under the pressure versus time curve in the final 180 days before death or exit from study
Number of subjects: 790
Study: 25436635

Group type: EXPERIMENTAL
Intervention: 3 sets × 8 repetitions × 3‐minute recovery at 70% 1RM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 sets × 14 repetitions × 3‐minute recovery at 40% 1RM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 sets × MNR (maximum number of repetitions) × 1‐minute recovery at 70% 1RM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 sets × MNR × 3‐minute recovery at 70% 1RM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 sets × MNR × 1‐minute recovery at 40% 1RM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 sets × MNR × 3‐minute recovery at 40% 1RM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 15-minute postexercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30-minute postexercise
Number of subjects: 0
Study: 23489113

Group type: EXPERIMENTAL
Intervention: Continuous infusion of terlipressin (4 mg/24 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bolus injection of terlipressin (2 mg) followed by intermittent injections (1 mg/6 h)
Number of subjects: 20
Study: 21520588

Group type: EXPERIMENTAL
Intervention: Remifentanil anesthesia (R)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Epidural anesthesia (E)
Number of subjects: 51
Study: 18623165

Group type: EXPERIMENTAL
Intervention: Pediatric onset IBD patients
Number of subjects: 368

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 368
Study: 16415702

Group type: EXPERIMENTAL
Intervention: 50 mg tramadol
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 15046380

Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Meloxicam (7.5 mg)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: All three drugs (nimesulide, meloxicam, rofecoxib)
Number of subjects: 127
Study: 11467457

Group type: EXPERIMENTAL
Intervention: Dual-coil lead system
Number of subjects: 83

Group type: COMPARATOR
Intervention: Single-coil lead system
Number of subjects: 83
Study: 9836480

Group type: EXPERIMENTAL
Intervention: Paclitaxel and cisplatin
Number of subjects: 4

Group type: COMPARATOR
Intervention: Cisplatin (single-agent, higher dose)
Number of subjects: 4
Study: 8157946

Group type: EXPERIMENTAL
Intervention: Captopril (average dose 72 mg/day for 24 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26